Literature DB >> 8757527

Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis.

P Anderlini1, D Przepiorka, D Seong, R Champlin, M Körbling.   

Abstract

Thirteen normal adult donors underwent daily leukapheresis for peripheral blood progenitor cell collection for allografting beginning on day 4 or 5 of G-CSF mobilization (12 micrograms/kg/d). They had complete blood counts performed 7-10 d after the completion of the procedure. A reduction in the total leucocyte count below baseline levels, accounted for by a decrease in the absolute neutrophil (ANC) and lymphocyte counts, was noted. Neutropenia (ANC < 1.5 x 10(9)/l) occurred in two (15%) of the donors. The lowest ANC observed was 0.6 x 10(9)/l. The neutropenia was asymptomatic and resolved on follow-up evaluation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757527     DOI: 10.1046/j.1365-2141.1996.d01-1778.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

Authors:  David F Stroncek; Bronwen E Shaw; Brent R Logan; Deidre M Kiefer; Bipin N Savani; Paolo Anderlini; Christopher N Bredeson; Peiman Hematti; Siddhartha Ganguly; Miguel Angel Diaz; Hisham Abdel-Azim; Ibrahim Ahmed; Dipnarine Maharaj; Matthew Seftel; Amer Beitinjaneh; Sachiko Seo; Jean A Yared; Joerg Halter; Paul V O'Donnell; Gregory A Hale; Zachariah DeFilipp; Hillard Lazarus; Jane L Liesveld; Zheng Zhou; Pashna Munshi; Richard F Olsson; Kimberly Anne Kasow; Jeffrey Szer; Galen E Switzer; Pintip Chitphakdithai; Nirali Shah; Dennis L Confer; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-25       Impact factor: 5.742

Review 2.  Concise review: next-generation cell therapies to prevent infections in neutropenic patients.

Authors:  Marion E G Brunck; Lars K Nielsen
Journal:  Stem Cells Transl Med       Date:  2014-03-05       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.